DexCom (DXCM) Tops Q2 EPS by 5c, Names CFO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
DexCom (DXCM) PT Lowered to $90 at BMO Capital Following 2Q on 'Near-Term Medicare Reimbursement Disruption'
August 2, 2017 9:49 AM EDTBMO Capital lowered its price target on DexCom (NASDAQ: DXCM) to $90.00 (from $105.00) while maintaining a Outperform rating, following the company's second quarter earnings announcement.
Analyst Joanne Wuensch notes the company delivered second quarter earnings per share and revenue results above consensus projections, while... More
DexCom (DXCM) PT Lowered to $92 at Oppenheimer Following 2Q
August 2, 2017 9:36 AM EDTOppenheimer lowered its price target on DexCom (NASDAQ: DXCM) to $92.00 (from $98.00) while maintaining a Outperform rating. 2Q17 revenue of $170.6M was ahead of the consensus estimate of $166.6M. The beat was both in the US and international. US sales were ~$140.8M, above... More



